NYSCHP CE: Aducanumab for Alzheimer's disease: love it or hate it?

 

November 16, 2021
5:30 PM - 6:30 PM
Add to Calendar

 

Zoom

Learning objectives for pharmacists:
1. Describe how aducanumab works in the setting of Alzheimer's disease.
2. Discuss the data behind the FDA approval of aducanumab.
3. Determine the appropriate use of aducanumab.
Learning objective for technicians:
1. Describe how to prepare aducanumab.
2. Identify how to store aducanumab.
3. Recognize the different drug classes used to treat Alzheimer's disease.

Tickets

$0.00 member ticket - free

$0.00 Non-member ticket - free